ClinicalTrials.gov
public full text
Public Domain
Precise Evaluation Criteria for Histological Regression of NASH Fibrosis
It is an observational study of NASH patients with a calculated sample size of 220. Liver biopsy-proven NASH fibrosis with stage F2-F4 will be recruited in this study. A second biopsy will be performed after clinical trials or 1-3 years of lifestyle intervention. Patients will be followed up at baseline and every six months with h-CRP, liver function tests, fasting blood glucose, fasting insulin, ferritin, liver ultrasonography, and liver stiffness measurements.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH)#1124931
- Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus#1164186
- Non-invasive Evaluation of Liver Fibrosis, Steatosis, and NASH in NAFLD#1112121
- Non-invasive Tests for Non-alcoholic Steato-hepatitis#993447
- Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic Ultrasound#898836
Record · ID 992227
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive